A

ATOS

Atossa Therapeutics Inc

0.76

0.02+3.22%
After Hours: 0.7551  -0.00  -0.15%19:46 04/25 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Cash from Operating Activities

-21.03M

-20.94M

-20.76M

-16.47M

-11.57M

Net Income

-25.50M

-30.09M

-26.96M

-20.61M

-17.83M

Depreciation/Depletion & Amortization

17.00K

23.00K

8.00K

23.00K

46.52K

Deferred Taxes

--

--

--

--

--

Non-Cash Items

4.01M

8.35M

7.12M

4.83M

6.43M

Changes in Working Capital

448.00K

776.00K

-928.00K

-719.00K

-216.07K

Cash from Investing Activities

-19.00K

-14.00K

-4.73M

-9.00K

-9.37K

Capital Expenditures

-19.00K

-14.00K

-27.00K

-9.00K

-9.37K

Other Investing Cash Flow Items, Total

--

0

-4.70M

--

--

Cash from Financing Activities

3.67M

-1.48M

0

113.30M

38.55M

Financing Cash Flow Items

--

--

--

--

--

Total Cash Dividends Paid

--

--

--

--

--

Issuance (Retirement) of Stock, Net

3.67M

-1.48M

0

113.30M

38.55M

Issuance (Retirement) of Debt, Net

--

--

--

--

--

Foreign Exchange Effects

--

--

--

--

--

Net Change in Cash

-17.38M

-22.43M

-25.49M

96.82M

26.97M

Cash Interest Paid

--

--

--

--

--

Cash Taxes Paid

--

--

--

--

--